Kiniksa Pharmaceuticals International, plc
 
 
 
 
公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
公司地址 105 Piccadilly, Second Floor, London, GBR, W1J 7NJ
電話號碼 +44 7814319100
傳真號碼 --
公司網頁 https://www.kiniksa.com
員工數量 366
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Michael R. Megna Chief Accounting Officer and Senior Vice President, Finance -- 16/04/2026
Mr. Sanj K. Patel Chief Executive Officer and Chairman of the Board 美元 943.13K 16/04/2026
Dr. John F. Paolini, M.D. Executive Vice President and Chief Medical Officer 美元 585.09K 16/04/2026
Mr. Mark Ragosa Executive Vice President and Chief Financial Officer 美元 552.80K 16/04/2026
Mr. Ross Moat President and Chief Operating Officer 美元 586.27K 22/10/2026
 
董事會成員
董事會 職務 更新日期
Dr. Barry D. Quart,Pharm.D. Independent Director 16/04/2026
Mr. G. Bradley Cole Independent Director 16/04/2026
Ms. Kimberly J. Popovits Independent Director 16/04/2026
Mr. Thomas R. Malley Independent Director 16/04/2026
Dr. Felix J. Baker, PhD Lead Independent Director 16/04/2026
Dr. Stephen R. Biggar,M.D.,PhD Independent Director 16/04/2026
Dr. Richard S. Levy,M.D. Independent Director 16/04/2026
Mr. Sanj K. Patel Chief Executive Officer and Chairman of the Board 16/04/2026
Ms. Tracey L. McCain, Esq. Independent Director 16/04/2026
Ms. Meta Cantey Boyd Independent Director 16/04/2026
 
所屬ETF (更新日期: 24/10/2026 03:23)
代號 名稱 佔比% ▼ 持有日期
TNXTT. Rowe Price Innovation Leaders ETF0.0004%30/09/2026
AESGHarbor AlphaEdge Small Cap Growth ETF0.0004%30/09/2026
AESBHarbor AlphaEdge Small Cap Core ETF0.0002%30/09/2026
PBSMInvesco PureBeta MSCI USA Small Cap ETF0.0002%31/05/2023
FFFFounders 100 ETF0.0001%30/09/2026
RESMColumbia Research Enhanced Small Cap ETF0.0001%30/09/2026
SQLTIshares MSCI USA Small-Cap Qul Fac ETF0.0001%30/09/2026
HDGProShares Hedge Replication0.0001%30/09/2026
EBILongview Advantage ETF0.0001%30/09/2026
ABLSAbacus FCF Small Cap Leaders ETF0.0001%30/09/2026
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF0.00003%30/09/2026
RBProshares Russell 2000 Dynamic BufferETF0.00002%30/09/2026
BOUTCapForce IBD® Breakout Opportunities ETF<0.000001%30/09/2026
HYPGolden Eagle Dynamic Hypergrowth ETF<0.000001%30/09/2026
  1    2    3   4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.